Research programme: amyloid precursor protein secretase inhibitors - ESBATech
Latest Information Update: 06 Dec 2010
At a glance
- Originator ESBATech
- Class Small molecules
- Mechanism of Action Amyloid precursor protein secretase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 19 May 2005 This programme is available for licensing (http://www.esbatech.com)
- 26 Mar 2004 Preclinical trials in Alzheimer's disease in Switzerland (unspecified route)